SynthesisBMC nephrology2025

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated meta-analysis of randomized controlled trials.

Shaikh Muhammad Daniyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.